← back to search

Allan Lawrie

Imperial College London · GB
🔎 Find collaborators in Pulmonary and Respiratory Medicine · Cardiology and Cardiovascular Medicine →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Pulmonary and Respiratory Medicine · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Pulmonary Hypertension Research and Treatments, Cardiovascular Function and Risk Factors, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, and MicroRNA in disease regulation.
h-index
62
citations
11,400
works
288
NIH funding
primary concept
Medicine
email

Recent publications

Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in Pulmonary Hypertension in Interstitial Lung Disease: A PVRI GoDeep Meta-Registry Analysis
American Journal of Respiratory and Critical Care Medicine 2025cited by 8position: middledoi
Precision Medicine for Pulmonary Vascular Disease: The Future Is Now (2023 Grover Conference Series)
Pulmonary Circulation 2025cited by 3position: middledoi
Male survival disadvantage in pulmonary hypertension: independent of aetiology, age, disease severity, comorbidities and treatment
EBioMedicine 2025cited by 2position: middledoi
Chronic thromboembolic pulmonary hypertension is an uncommon complication of COVID-19: UK national surveillance and observational screening cohort studies
European Respiratory Journal 2024cited by 7position: middledoi
Wearable technology and the cardiovascular system: the future of patient assessment
The Lancet Digital Health 2023cited by 120position: middledoi
Defining the clinical validity of genes reported to cause pulmonary arterial hypertension
Genetics in Medicine 2023cited by 70position: middledoi
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
Cell 2021cited by 352position: middledoi
Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH
Genome Medicine 2021cited by 84position: middledoi
Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole blood
Nature Communications 2021cited by 54position: middledoi
Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical Outcome
American Journal of Respiratory and Critical Care Medicine 2020cited by 72position: middledoi
Bayesian Inference Associates Rare <i>KDR</i> Variants With Specific Phenotypes in Pulmonary Arterial Hypertension
Circulation Genomic and Precision Medicine 2020cited by 46position: middledoi
Germline selection shapes human mitochondrial DNA diversity
Science 2019cited by 250position: middledoi
Characterization of <i>GDF2</i> Mutations and Levels of BMP9 and BMP10 in Pulmonary Arterial Hypertension
American Journal of Respiratory and Critical Care Medicine 2019cited by 122position: middledoi
Loss of Endothelial Endoglin Promotes High-Output Heart Failure Through Peripheral Arteriovenous Shunting Driven by VEGF Signaling
Circulation Research 2019cited by 69position: middledoi
Identification of rare sequence variation underlying heritable pulmonary arterial hypertension
Nature Communications 2018cited by 380position: middledoi
Telomerecat: A ploidy-agnostic method for estimating telomere length from whole genome sequencing data
Scientific Reports 2018cited by 90position: middledoi
Loss-of-Function <i>ABCC8</i> Mutations in Pulmonary Arterial Hypertension
Circulation Genomic and Precision Medicine 2018cited by 81position: middledoi
Phenotypic Characterization of <i>EIF2AK4</i> Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension
Circulation 2017cited by 144position: middledoi
Hypoxia determines survival outcomes of bacterial infection through HIF-1α–dependent reprogramming of leukocyte metabolism
Science Immunology 2017cited by 79position: middledoi
Low-Dose FK506 (Tacrolimus) in End-Stage Pulmonary Arterial Hypertension
American Journal of Respiratory and Critical Care Medicine 2015cited by 115position: middledoi
P157 Hepatocyte growth factor concentration correlates with haemodynamic severity in connective tissue disease-associated pulmonary arterial hypertension
Thorax 2013cited by 0position: lastdoi
Reduced MicroRNA-150 Is Associated with Poor Survival in Pulmonary Arterial Hypertension
American Journal of Respiratory and Critical Care Medicine 2012cited by 171position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Martin R. Wilkins · Imperial College London2 papers (2012–2023)Robin Condliffe · Royal Hallamshire Hospital2 papers (2012–2013)Hossein Ardeschir Ghofrani · Justus-Liebig-Universität Gießen1 papers (2012–2012)Matthew A. Bill · The Ohio State University1 papers (2015–2015)Anob M. Chakrabarti · University of Sheffield1 papers (2012–2012)Charles Elliot · University of Sheffield1 papers (2012–2012)Yixin Wang · Shanghai Jiao Tong University1 papers (2019–2019)Hilda Tsang · University of Colorado Denver1 papers (2012–2012)Hua Lin · University of Nottingham1 papers (2019–2019)Paul Morris · Sheffield Teaching Hospitals NHS Foundation Trust1 papers (2023–2023)Esha Singh · Newcastle University1 papers (2019–2019) · 1 papers (2013–2013) · 1 papers (2013–2013) · 1 papers (2012–2012) · 1 papers (2013–2013)RT Zamanian · Palo Alto University1 papers (2013–2013)D. Rodney Hose · University of Sheffield1 papers (2023–2023)Luke Howard · Imperial College Healthcare NHS Trust1 papers (2012–2012)Lars Jakobsson · Karolinska Institutet1 papers (2019–2019)Phillip C. Yang · Palo Alto University1 papers (2015–2015)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Pulmonary and Respiratory Medicine · Cardiology and Cardiovascular Medicine →